Skip to main content
. 2021 Jul 29;12(8):1177. doi: 10.3390/genes12081177

Table 3.

Frequency of ACE and ACTN3 variants in study subjects.

ACE Subjects (n = 80)
II 10 (12.5%)
ID 39 (48.8%)
DD 31 (38.8%)
ACTN3 Subjects (n = 80)
RR 33 (41.3%)
RX 36 (45.0%)
XX 11 (13.8%)